Specialties
Reports that name this provider
- Stem Cell Legality in India
- Joint enterprise of Manipal Education and Medical Group and Cipla Group; developed and commercialized Stempeucel (cultured adult allogeneic mesenchymal stem cells from bone marrow) approved for treating critical limb ischemia attributable to Buerger's disease
- Stem Cell Therapy Quality in India
- Received regulatory approval from DCGI for limited marketing of Stempeucel® for critical limb ischemia; product derived from allogeneic pooled mesenchymal stromal cells from adult bone marrow; patented in US, Japan, China and Malaysia; based on phase-1 and phase-2 trials on 90 subjects with Buerger's disease showing significant improvement in blood flow compared to placebo or control